These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29978954)

  • 21. Subtle changes in striatal muscarinic M1 and M4 receptor expression in the DYT1 knock-in mouse model of dystonia.
    Richter F; Klein L; Helmschrodt C; Richter A
    PLoS One; 2019; 14(12):e0226080. PubMed ID: 31805123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinociceptive effects of potent, selective and brain penetrant muscarinic M
    Grauer SM; Sanoja R; Poulin D; Rashid H; Jochnowitz N; Calhoun M; Zwilling D; Varty GB; Rosahl TW; Meziane H; Mittlelhaeuser C; Mazzola R; Morrow J; Smith SM; Henze D; Marcus J
    Brain Res; 2020 Jun; 1737():146814. PubMed ID: 32234514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired functional organization in the visual cortex of muscarinic receptor knock-out mice.
    Groleau M; Nguyen HN; Vanni MP; Huppé-Gourgues F; Casanova C; Vaucher E
    Neuroimage; 2014 Sep; 98():233-42. PubMed ID: 24837499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The M4 muscarinic acetylcholine receptor plays a key role in the control of murine hair follicle cycling and pigmentation.
    Hasse S; Chernyavsky AI; Grando SA; Paus R
    Life Sci; 2007 May; 80(24-25):2248-52. PubMed ID: 17346754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.
    Fink-Jensen A; Schmidt LS; Dencker D; Schülein C; Wess J; Wörtwein G; Woldbye DP
    Eur J Pharmacol; 2011 Apr; 656(1-3):39-44. PubMed ID: 21269601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
    Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA
    Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
    Watt ML; Rorick-Kehn L; Shaw DB; Knitowski KM; Quets AT; Chesterfield AK; McKinzie DL; Felder CC
    Neuropsychopharmacology; 2013 Dec; 38(13):2717-26. PubMed ID: 23907402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
    Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
    Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice.
    Schmidt LS; Thomsen M; Weikop P; Dencker D; Wess J; Woldbye DP; Wortwein G; Fink-Jensen A
    Psychopharmacology (Berl); 2011 Aug; 216(3):367-78. PubMed ID: 21373792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of muscarinic receptor subtypes in acetylcholine release from urinary bladder obtained from muscarinic receptor knockout mouse.
    Takeuchi T; Yamashiro N; Kawasaki T; Nakajima H; Azuma YT; Matsui M
    Neuroscience; 2008 Oct; 156(2):381-9. PubMed ID: 18755247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.
    Gomeza J; Zhang L; Kostenis E; Felder CC; Bymaster FP; Brodkin J; Shannon H; Xia B; Duttaroy A; Deng CX; Wess J
    Life Sci; 2001 Apr; 68(22-23):2457-66. PubMed ID: 11392613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of dexras1 alters nonphotic circadian phase shifts and reveals a role for the intergeniculate leaflet (IGL) in gene-targeted mice.
    Koletar MM; Cheng HY; Penninger JM; Ralph MR
    Chronobiol Int; 2011 Aug; 28(7):553-62. PubMed ID: 21834641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.
    Veeraragavan S; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
    Behav Neurosci; 2011 Oct; 125(5):783-90. PubMed ID: 21942438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutual activation of glutamatergic mGlu
    Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM
    Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.
    Tzavara ET; Bymaster FP; Davis RJ; Wade MR; Perry KW; Wess J; McKinzie DL; Felder C; Nomikos GG
    FASEB J; 2004 Sep; 18(12):1410-2. PubMed ID: 15231726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.
    Takeuchi T; Fujinami K; Goto H; Fujita A; Taketo MM; Manabe T; Matsui M; Hata F
    J Neurophysiol; 2005 May; 93(5):2841-8. PubMed ID: 15574798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.
    Nair AG; Castro LRV; El Khoury M; Gorgievski V; Giros B; Tzavara ET; Hellgren-Kotaleski J; Vincent P
    Neuropharmacology; 2019 Mar; 146():74-83. PubMed ID: 30468798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus.
    Kohlmeier KA; Ishibashi M; Wess J; Bickford ME; Leonard CS
    J Neurophysiol; 2012 Nov; 108(10):2751-66. PubMed ID: 22956788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway.
    Luo L; Zhang G; Mao L; Wang P; Xi C; Shi G; Leavenworth JW
    Toxicol Appl Pharmacol; 2020 May; 395():114978. PubMed ID: 32234387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.